GeneTex

Founded in 1997, GeneTex develops antibodies, recombinant proteins, lysates and research reagents for biomedical research, assay development and in vitro diagnostic development. The company specialises in antibody generation and validation, with expertise spanning polyclonal, monoclonal and recombinant monoclonal antibody technologies. Its product development platform incorporates recombinant antibody production and rigorous validation strategies designed to support reliable data generation across a wide range of experimental workflows. GeneTex products are used in applications including immunohistochemistry, western blotting, ELISA, flow cytometry and immunofluorescence, supporting research in cancer biology, immunology, neuroscience, infectious disease, cell biology, epigenetics and cell signalling.

The GeneTex portfolio includes primary and secondary antibodies, recombinant proteins, cell lysates, antibody labelling kits and immunoblotting reagents. Notable product families include HistoMAX™ monoclonal antibodies for immunohistochemistry, FSD Fluor™ antibody labelling kits for antibody conjugation workflows and Trident™ western blot reagents for chemiluminescent detection. The company also provides a broad range of reagents for GPCR biology, biomarker research and translational studies, enabling researchers to investigate protein expression, localisation and function across diverse model systems.